Amir Shojaei

Lifitegrast for the Treatment of Dry Eye Disease

Edward J. Holland, Jodi Luchs, Paul Karpecki et al. · Ophthalmology · 2016 · 196 citations · Full text

Pharmacokinetics of a Guanfacine Extended‐Release Formulation in Children and Adolescents with Attention‐Deficit–Hyperactivity Disorder

Samuel W. Boellner, Michael Pennick, K.Suzanne Fiske et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2007 · 58 citations

A phase i, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults

Dennis Swearingen, Michael Pennick, Amir Shojaei et al. · Clinical Therapeutics · 2007 · 38 citations

Therapeutic Drug Monitoring, Medicine, 4-Mg Tablets +5

Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials

Edward J. Holland, Walter O. Whitley, Kenneth Sall et al. · Current Medical Research and Opinion · 2016 · 36 citations · Full text

Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease

Kelly K. Nichols, Eric D. Donnenfeld, Paul Karpecki et al. · European Journal of Ophthalmology · 2018 · 36 citations · Full text